This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Vandetanib to Treat Children and Adolescents With ...
Clinical trial

Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

Read time: 1 mins
Last updated:14th Mar 2012
To study the activity of Vandetanib in children and adolescents with MEN-related MTC by measuring the change in tumor size, in blood levels of proteins produced the tumor (calcitonin and CEA) and in tumor-related diarrhea. To determine the safety and tolerability of Vandetanib in children and adolescents. To study how the body handles Vandetanib in children and adolescents. To determine the effect of Vandetanib on the survival of children and adolescents with MTC.
Category Value
Study start date 2012-03-14

View full details